01 / PSC Market Profile
PSC 6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets Federal Contracts
Product and Service Code 6550
Federal contract activity classified under In Vitro Diagnostic Substances, Reagents, Test Kits And Sets across FY 2020–FY 2026. Net obligations include both new obligations and subsequent deobligations.
02 / Market Size
How large is the PSC 6550 federal market?
03 / Spending Trend
PSC 6550 contract spending by fiscal year
Annual obligations, activity, and participation across the same FY 2020–FY 2026 profile window.
Latest closed fiscal year$201.16M
FY 2026| Fiscal year | Obligations | Actions | Vendors | Customers | Change |
|---|---|---|---|---|---|
| FY 2020 | $343.83M | 5,369 | 336 | 25 | — |
| FY 2021 | $597.87M | 5,907 | 350 | 28 | +73.9% |
| FY 2022 | $1.22B | 5,418 | 324 | 32 | +104.6% |
| FY 2023 | $1.07B | 5,107 | 319 | 28 | −12.5% |
| FY 2024 | $211.13M | 5,338 | 308 | 29 | −80.3% |
| FY 2025 | $189.63M | 5,555 | 288 | 22 | −10.2% |
| FY 2026 | $201.16M | 4,188 | 248 | 19 | +6.1% |
04 / Top Federal Customers
Which federal agencies buy most in this industry?
Ranked by net obligations during FY 2020–FY 2026.
| Federal customer | Code | Obligations | Actions | Vendors | Market share |
|---|---|---|---|---|---|
| DEPT OF THE ARMY | 2100 | $1.33B | 3,497 | 145 | 34.7% |
| VETERANS AFFAIRS, DEPARTMENT OF | 3600 | $892.16M | 10,412 | 195 | 23.2% |
| ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE | 7505 | $881.34M | 51 | 12 | 23.0% |
| DEFENSE LOGISTICS AGENCY | 97AS | $183.25M | 15,032 | 111 | 4.8% |
| DEPT OF THE AIR FORCE | 5700 | $155.73M | 978 | 48 | 4.1% |
| INDIAN HEALTH SERVICE | 7527 | $104.88M | 1,422 | 66 | 2.7% |
| DEFENSE HEALTH AGENCY (DHA) | 97DH | $83.27M | 1,232 | 120 | 2.2% |
| DEPT OF THE NAVY | 1700 | $66.21M | 1,945 | 139 | 1.7% |
| NATIONAL INSTITUTES OF HEALTH | 7529 | $55.59M | 1,056 | 163 | 1.4% |
| FOOD AND DRUG ADMINISTRATION | 7524 | $20.66M | 307 | 38 | 0.5% |
05 / Contracting Offices
Which contracting offices buy in PSC 6550?
Ranked by net obligations during FY 2020–FY 2026.
| Office | Code | Agency | Obligations | Actions | Vendors | Market share |
|---|---|---|---|---|---|---|
| W6QK ACC-APG NATICK | W58P05 | DEPT OF THE ARMY | $862.97M | 8 | 1 | 22.5% |
| ASPR/DAAPPO/ORM HQ | 75A502 | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | $851.20M | 19 | 9 | 22.2% |
| W6QK ACC-APG NATICK | W911QY | DEPT OF THE ARMY | $267.92M | 53 | 9 | 7.0% |
| SAC FREDERICK (36C10X) | 36C10X | VETERANS AFFAIRS, DEPARTMENT OF | $153.89M | 23 | 5 | 4.0% |
| 262-NETWORK CONTRACT OFFICE 22 (36C262) | 36C262 | VETERANS AFFAIRS, DEPARTMENT OF | $102.73M | 875 | 61 | 2.7% |
| 257-NETWORK CONTRACT OFFICE 17 (36C257) | 36C257 | VETERANS AFFAIRS, DEPARTMENT OF | $92.73M | 1,006 | 50 | 2.4% |
| DLA TROOP SUPPORT | SPE2DS | DEFENSE LOGISTICS AGENCY | $80.33M | 14,666 | 100 | 2.1% |
| W40M MRC0 WEST | W81K00 | DEPT OF THE ARMY | $79.32M | 1,363 | 57 | 2.1% |
| 241-NETWORK CONTRACT OFFICE 01 (36C241) | 36C241 | VETERANS AFFAIRS, DEPARTMENT OF | $78.61M | 919 | 56 | 2.0% |
| DLA TROOP SUPPORT | SPE2D1 | DEFENSE LOGISTICS AGENCY | $76.22M | 3 | 3 | 2.0% |
06 / Top Vendors
Which contractors lead the PSC 6550 market?
| Vendor | Obligations | Actions | Customers | Market share | Latest activity |
|---|---|---|---|---|---|
| ASTRAZENECA PHARMACEUTICALS LP | $1.11B | 12 | 1 | 28.9% | Aug 3, 2023 |
| ABBOTT RAPID DX NORTH AMERICA, LLC | $365.77M | 247 | 11 | 9.5% | Sep 25, 2026 |
| ROCHE DIAGNOSTICS CORPORATION | $246.84M | 1,710 | 11 | 6.4% | Sep 29, 2026 |
| OSANG LLC | $237.00M | 4 | 1 | 6.2% | Jul 14, 2025 |
| CEPHEID | $203.22M | 1,152 | 8 | 5.3% | Sep 23, 2026 |
| BECTON, DICKINSON AND COMPANY | $175.39M | 408 | 8 | 4.6% | Sep 29, 2026 |
| ACCESS BIO, INC. | $135.45M | 6 | 1 | 3.5% | Nov 7, 2024 |
| QUIDEL CORPORATION | $120.71M | 43 | 7 | 3.1% | Apr 23, 2026 |
| ABBOTT LABORATORIES | $94.00M | 600 | 9 | 2.4% | Aug 31, 2026 |
| BIOMERIEUX , INC. | $88.94M | 1,254 | 9 | 2.3% | Sep 29, 2026 |
07 / Industry Mix
What industries are purchased under PSC 6550?
| NAICS | Description | Obligations | Actions | Vendors | Share |
|---|---|---|---|---|---|
| 325413 | IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING | $1.72B | 14,373 | 373 | 44.7% |
| 325412 | PHARMACEUTICAL PREPARATION MANUFACTURING | $1.43B | 859 | 77 | 37.4% |
| 334516 | ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING | $553.51M | 7,317 | 165 | 14.4% |
| 325414 | BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING | $35.21M | 672 | 96 | 0.9% |
| 621511 | MEDICAL LABORATORIES | $16.09M | 205 | 52 | 0.4% |
| 334519 | OTHER MEASURING AND CONTROLLING DEVICE MANUFACTURING | $14.01M | 36 | 11 | 0.4% |
| 339112 | SURGICAL AND MEDICAL INSTRUMENT MANUFACTURING | $13.83M | 578 | 60 | 0.4% |
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | $12.99M | 120 | 48 | 0.3% |
| 621991 | BLOOD AND ORGAN BANKS | $8.64M | 119 | 13 | 0.2% |
| 541380 | TESTING LABORATORIES AND SERVICES | $6.09M | 124 | 27 | 0.2% |
08 / Buying Pattern
How does the government buy in PSC 6550?
| Common action type | Obligations | Actions |
|---|---|---|
| PURCHASE ORDER | $447.32M | 21,548 |
| DELIVERY ORDER | $762.64M | 9,759 |
| BPA CALL | $371.22M | 4,821 |
| DEFINITIVE CONTRACT | $2.26B | 754 |
09 / Recent Contract Awards
What was awarded most recently in PSC 6550?
10 / Market Interpretation
How should contractors evaluate this market?
Start with the spending direction
Compare annual obligations with actions and vendor participation. Growth driven by only a few large actions represents a different opportunity from broad, recurring demand.
Follow the actual buyers
Move from federal customers to contracting offices. Offices reveal where acquisition responsibility and recurring purchasing activity are concentrated.
Measure accessible demand
Use competition, small-business participation, incumbent vendors, and PSC mix before treating the full $3.84B market as addressable.